Biomea Debt Current from 2010 to 2024
| BMEA Stock | USD 10.83 0.02 0.18% |
Check Biomea Fusion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomea main balance sheet or income statement drivers, such as Net Interest Income of 9.3 M, Interest Income of 9.3 M or Depreciation And Amortization of 834.4 K, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.15. Biomea financial statements analysis is a perfect complement when working with Biomea Fusion Valuation or Volatility modules.
Biomea | Debt Current |
About Biomea Fusion Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Biomea Fusion income statement, its balance sheet, and the statement of cash flows. Biomea Fusion investors use historical funamental indicators, such as Biomea Fusion's Debt Current, to determine how well the company is positioned to perform in the future. Although Biomea Fusion investors may use each financial statement separately, they are all related. The changes in Biomea Fusion's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biomea Fusion's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Biomea Fusion Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Biomea Fusion. Please read more on our technical analysis and fundamental analysis pages.
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. The company was incorporated in 2017 and is headquartered in Redwood City, California. Biomea Fusion operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biomea Fusion in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biomea Fusion's short interest history, or implied volatility extrapolated from Biomea Fusion options trading.
Pair Trading with Biomea Fusion
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomea Fusion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will appreciate offsetting losses from the drop in the long position's value.Moving together with Biomea Stock
| 0.66 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.65 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Biomea Stock
| 0.61 | ELYM | Eliem Therapeutics | PairCorr |
| 0.45 | OPT | Opthea | PairCorr |
| 0.45 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
| 0.44 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
| 0.43 | AVTE | Aerovate Therapeutics Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Biomea Fusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomea Fusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomea Fusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomea Fusion to buy it.
The correlation of Biomea Fusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomea Fusion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomea Fusion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biomea Fusion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Biomea Fusion Correlation against competitors. For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.Note that the Biomea Fusion information on this page should be used as a complementary analysis to other Biomea Fusion's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Biomea Stock analysis
When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Biomea Fusion's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.44) | Return On Assets (0.48) | Return On Equity (0.84) |
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.